| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.031 | 0.8 |